Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 2/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9063834 | 0.92 | ZDHHC20 (0.42) | THRBTSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL8079136 | 0.86 | TSHR (0.42) | THRBTSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL17522107 | 0.83 | TSHR (0.39) | THRBTSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL29263179 | 0.83 | THRB (0.46) | THRBTSHRALDH1A1TDP1CHRM2 | |
| SCHEMBL3818410 | 0.83 | THRB (0.46) | THRBTSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL20723256 | 0.82 | TSHR (0.50) | THRBTSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL17522072 | 0.82 | ZDHHC20 (0.43) | THRBTSHRALDH1A1MAPK1TDP1 | |
| Acrylic Acid SCHEMBL1942618 | 0.82 | THRB (0.44) | THRBTSHRALDH1A1TDP1CHRM2 | |
| Methacrylic Acid SCHEMBL28850506 | 0.82 | ALDH1A1 (0.50) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| Butadiene SCHEMBL29263181 | 0.81 | THRB (0.47) | THRBTSHRALDH1A1TDP1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1518870-B1 | SEPARATING MATERIAL | GAMBRO LUNDIA AB (SE) | 2018-11-28 | — | — | EP | disclosed |
| EP-2261271-B1 | SEPARATION MATERIAL | GAMBRO LUNDIA AB (SE) | 2014-04-30 | — | — | EP | disclosed |
| US-8303819-B2 | Separation material | GAMBRO LUNDIA AB (SE) | 2012-11-06 | — | — | US | disclosed |
| US-20120160771-A1 | Separation Material | GAMBRO LUNDIA AB (SE) | 2012-06-28 | — | — | US | disclosed |
| US-8142844-B2 | Separating material | GAMBRO LUNDIA AB (SE) | 2012-03-27 | — | — | US | disclosed |
| EP-2261271-A1 | Separation material | Gambro Lundia AB (SE) | 2010-12-15 | — | — | EP | disclosed |
| US-20060264355-A1 | Separating material | GAMBRO LUNDIA AB | 2006-11-23 | — | — | US | disclosed |
| EP-1518870-A1 | Separating material | Gambro Lundia AB (SE) | 2005-03-30 | — | — | EP | disclosed |
| WO-2005026224-A1 | SEPARATING MATERIAL | GAMBRO LUNDIA AB (SE) | 2005-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264355-A1 | Separating material | ILK, PCNA, HLA-B | THRB 4877/4885TSHR 4880/4885ALDH1A1 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.